BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 12, 2019
View Archived Issues
RHEB gene brain somatic mutation may cause focal cortical dysplasia type II
Read More
New antibody targets CAF-derived antigens in ovarian and pancreatic cancer
Read More
Phase I safety and immunogenicity data for GLS-5300 MERS vaccine
Read More
BI-2852 directly inhibits KRAS by binding to a pocket previously thought undruggable
Read More
Phase III results for fixed-dose combination of bempedoic acid plus ezetimibe
Read More
Children's Medical Center identifies new Rac-GTPase inhibitors
Read More
Array patents proto-oncogene tyrosine-protein kinase receptor Ret inhibitors
Read More
Brain diseases have shared superhighway vulnerabilities
Read More
PI3Kdelta inhibition may be useful in dementia
Read More
PCOS linked to interleukin-22 by way of microbiome
Read More
Ionis Pharmaceuticals describes oligonucleotides targeting human dynamin-2
Read More
New C5a-R antagonists identified at Idorsia Pharmaceuticals
Read More
GeneCentric enters second phase of academic-industry head and neck cancer partnership
Read More
Phase I study evaluates Fluzone and Flublok seasonal flu vaccines with two experimental adjuvants
Read More
AMPK-related kinases SIK1 and SIK3 identified as targets for non-small-cell lung cancer
Read More
Bristol-Myers Squibb initiates first-in-human study of BMS-986288
Read More
VenatoRx enrolling participants in phase III study of cefepime/VNRX-5133
Read More
Lysozyme inhibitors show promise for treating neuropathic pain
Read More
FDA clears IND application for first-in-human study of QR-1123
Read More
First patient enrolled in proof-of-concept trial of IMU-838 in primary sclerosing cholangitis
Read More